文献速递神经肿瘤

弥漫性WHO II级胶质瘤的手术治疗:德国术中磁共振研究组多中心回顾性队列的容积分析

Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging.
PubMed 文献 · Neurosurgery · 2020-01-01

该多中心回顾性队列纳入140例弥漫性WHO II级胶质瘤患者,容积量化术前术后肿瘤体积,分析残余体积与切除程度同无进展生存期或总生存期的关联。结果显示全切除较任何不完全切除的无进展生存期显著更长,即使小残余也见生存劣势,残余体积与切除程度为无进展生存期的连续预后因素。

要点

  • 全切除较任何不完全切除与显著更长的无进展生存期相关(P=.009)。
  • 即使小残余(>0-5 ml)也见显著生存劣势,中等(>5-20 ml)和大残余(>20 ml)更甚(P=.001)。
  • 残余体积与切除程度为无进展生存期的连续预后因素,多因素Cox回归P=.01和P=.005。

核心结论

  • 数据支持残余体积与切除程度同生存期呈连续关系,全切除者生存更优。
  • 作者认为应在安全可行时实现全切除,需保留功能而留下肿瘤时应最大化切除。

研究设计与样本

  • 德国术中磁共振研究组(GeSGIM)开展的多中心回顾性队列,连续评估5个中心的病例。
  • 共分析140例,术前术后对肿瘤进行容积量化,并分析IDH突变和神经功能缺损等临床数据。
  • 采用Kaplan-Meier估计、加速失效时间模型(AFT)和多因素Cox回归模型识别生存决定因素。

主要发现

  • 全切除较任何不完全切除与显著更长的无进展生存期相关(P=.009)。
  • 即使小残余(>0-5 ml)也见显著生存劣势,中等(>5-20 ml)和大残余(>20 ml)更甚(P=.001)。
  • 无进展生存期随切除程度每20%递增而持续增加(P<.001)。
  • AFT模型支持残余体积和切除程度与无进展生存期呈连续关联。
  • 多因素Cox回归证实残余体积(P=.01)和切除程度(P=.005)为无进展生存期的连续预后因素;单因素分析显示两者与总生存期显著相关。

临床怎么用

  • 作者认为应在安全可行时实现全切除,需保留功能而留下肿瘤时应最大化切除。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In diffuse WHO grade II gliomas (LGG), the extent of resection (EOR) required to achieve significant survival benefits remains elusive. OBJECTIVE: To evaluate the association of residual volume (RV) and EOR with progression-free survival (PFS) or overall survival (OS) in LGG in a retrospective, multicenter series by the German study group of intraoperative MRI (GeSGIM). METHODS: Consecutive cases were retrospectively assessed from 5 centers. Tumors were volumetrically quantified before and after surgery, and clinical data were analyzed, including IDH mutations and neurologic deficits. Kaplan-Meier estimates, accelerated failure time models (AFT), and multivariate Cox regression models were calculated to identify determinants of survival. RESULTS: A total of 140 cases were analyzed. Gross total resection (GTR) was associated with significantly longer PFS compared to any incomplete resection (P = .009). A significant survival disadvantage was evident even for small (>0-5 ml) residuals and increased for moderate (>5-20 ml) and large remnants (>20 ml) P = .001). Accordingly, PFS increased continuously for 20% incremental steps of EOR (P < .001). AFT models supported the notion of a continuous association of RV and EOR with PFS. Multivariate Cox regression models confirmed RV (P = .01) and EOR (P = .005) as continuous prognosticators of PFS. Univariate analysis showed significant associations of RV and EOR with OS. CONCLUSION: Our data support the hypothesis of a continuous relationship of RV and EOR with survival for LGG with superiority seen for GTR. Hence, GTR should be achieved whenever safely feasible, and resections should be maximized whenever tumor has to be left behind to spare function.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Scherer M, Ahmeti H, Roder C, et al. Surgery for Diffuse WHO Grade II Gliomas: Volumetric Analysis of a Multicenter Retrospective Cohort From the German Study Group for Intraoperative Magnetic Resonance Imaging. Neurosurgery. 2020. PMID: 31574147. doi:10.1093/neuros/nyz397

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。